WO2004103264A3 - Hemostatic antibacterial composition and products incorporating the same - Google Patents

Hemostatic antibacterial composition and products incorporating the same Download PDF

Info

Publication number
WO2004103264A3
WO2004103264A3 PCT/IN2004/000141 IN2004000141W WO2004103264A3 WO 2004103264 A3 WO2004103264 A3 WO 2004103264A3 IN 2004000141 W IN2004000141 W IN 2004000141W WO 2004103264 A3 WO2004103264 A3 WO 2004103264A3
Authority
WO
WIPO (PCT)
Prior art keywords
composition
same
antibacterial composition
products incorporating
making
Prior art date
Application number
PCT/IN2004/000141
Other languages
French (fr)
Other versions
WO2004103264A2 (en
Inventor
Mini Thomas
Ajit Sitaram Manke
Alain Khaiat
William Hart
Original Assignee
Johnson & Johnson Ltd
Mini Thomas
Ajit Sitaram Manke
Alain Khaiat
William Hart
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Ltd, Mini Thomas, Ajit Sitaram Manke, Alain Khaiat, William Hart filed Critical Johnson & Johnson Ltd
Publication of WO2004103264A2 publication Critical patent/WO2004103264A2/en
Publication of WO2004103264A3 publication Critical patent/WO2004103264A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/0005—Use of materials characterised by their function or physical properties
    • A61L33/007—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/204—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines
    • A61L2300/208—Quaternary ammonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/30—Compounds of undetermined constitution extracted from natural sources, e.g. Aloe Vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Abstract

This invention relates to a hemostatic antibacterial composition which comprises an extract of cephalanoplos segetum and benzalkonium chloride. Preferably a local anesthetic and a surfactant are added to this composition. This synergistic composition decreases blood coagulating time considerably. Local anesthetic used may be licodine hydrochloride. Medicament containing strips, pouches and compresses are included in this invention. Method of making this synergistic composition is by admixing the components under stirring. Medicament containing cotton or non-woven strips with the composition and making the desired products therewith.
PCT/IN2004/000141 2003-05-22 2004-05-21 Hemostatic antibacterial composition and products incorporating the same WO2004103264A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CNB031365353A CN1241651C (en) 2003-05-22 2003-05-22 Hemostatic antibiotic products and preparnig method thereof
CN03136535.3 2003-05-22

Publications (2)

Publication Number Publication Date
WO2004103264A2 WO2004103264A2 (en) 2004-12-02
WO2004103264A3 true WO2004103264A3 (en) 2005-02-17

Family

ID=33459838

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2004/000141 WO2004103264A2 (en) 2003-05-22 2004-05-21 Hemostatic antibacterial composition and products incorporating the same

Country Status (2)

Country Link
CN (1) CN1241651C (en)
WO (1) WO2004103264A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104888266A (en) * 2014-03-06 2015-09-09 李平 Haemostasis and antibiosis band, and production method and application thereof
US10039830B2 (en) * 2016-03-04 2018-08-07 Cetylite Industries, Inc. Topical anesthetic composition
CN108939130A (en) * 2017-05-21 2018-12-07 衢州玛济克医疗科技有限公司 A kind of bedsore medical dressing and its production method
CN108904859A (en) * 2018-07-23 2018-11-30 衢州玛济克医疗科技有限公司 A kind of hemorrhoid medical dressing and its production method
CN108853557A (en) * 2018-07-23 2018-11-23 衢州玛济克医疗科技有限公司 A kind of wet erythema medical dressing of infant and its production method
CN110339390A (en) * 2019-08-12 2019-10-18 中国中医科学院中药研究所 A kind of compounding adhesive bandage and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08301780A (en) * 1995-05-10 1996-11-19 Kao Corp Fat degradation-promoting agent
JPH09208483A (en) * 1996-01-30 1997-08-12 Kao Corp Preparation composition for external use for skin and bath agent composition

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08301780A (en) * 1995-05-10 1996-11-19 Kao Corp Fat degradation-promoting agent
JPH09208483A (en) * 1996-01-30 1997-08-12 Kao Corp Preparation composition for external use for skin and bath agent composition

Also Published As

Publication number Publication date
CN1241651C (en) 2006-02-15
CN1548167A (en) 2004-11-24
WO2004103264A2 (en) 2004-12-02

Similar Documents

Publication Publication Date Title
TW200518789A (en) Deployable multifunctional hemostatic agent
WO2005014533A3 (en) Aryl and heteroaryl compounds, compositions, and methods of use
WO2006096439A3 (en) Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases
MY143795A (en) Tetrahydropyridoindole derivatives
WO2003055531A8 (en) A hemostatic kit, a method of preparing a hemostatic agent and a method of promoting hemostasis
WO2005055944A3 (en) Oligosaccharide compositions and use thereof in the treatment of infection
TW200507807A (en) Deployable hemostatic agent
WO2006068841A3 (en) Hemostasis cuff for catheter securement
WO2005102392A3 (en) Combinations for treating hiv infection
WO2007064881A3 (en) Implantable microbial cellulose materials for various medical applications
WO2006086562A3 (en) Phenylazetidinone derivatives
WO2005016256A3 (en) Hemostatic compositions containing sterile thrombin
GEP20125565B (en) Lactam compounds and their pharmaceutical use
WO2002087563A3 (en) Compositions comprising an anti-microtubule agent and a polypeptide or a polysaccharide and the use thereof for the preparation of a medicament for the treatment of inflammatory conditions
HK1102546A1 (en) Hemostatic agent for topical and internal use
WO2006044362A3 (en) N-sulfonylpiperidine cannabinoid receptor 1 antagonists
WO2005027895A3 (en) Thyroid hormone analogs and methods of use in angiogenesis
WO2007002836A3 (en) Methods and compositions for the prevention and treatment of kidney disease
WO2006034001A3 (en) Methods of treating hiv infection
WO2004012655A3 (en) Anti-microbial compositions and methods of using same
EP2540301A3 (en) Methods and pharmaceutical compositions for healing wounds
EP1624752A4 (en) Delivery of compounds with rehydrated blood cells
WO2003018059A3 (en) Combination preparations of aryl substituted propanolamine derivatives with other active ingredients and the use thereof
WO2004103264A3 (en) Hemostatic antibacterial composition and products incorporating the same
WO2003066597A3 (en) Guanidino compounds

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase